Piramal Pharma Faces Significant Decline Amid Broader Market Weakness and Sector Underperformance

Piramal Pharma has experienced a significant decline today, with shares dropping by 4.98% as of July 29, 2025. The stock opened lower, reflecting a gap down of 3.84%, and reached an intraday low of Rs 193.3, marking a decrease of 5.55%. This performance indicates that Piramal Pharma has underperformed its sector by 5.02% today.
In terms of moving averages, Piramal Pharma is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend in the short to medium term. Over the past week, the stock has declined by 4.07%, while the Sensex has only fallen by 1.62%.

Looking at broader market trends, the Sensex opened lower at 80,620.25, down 270.77 points, and is currently trading at 80,855.69. The index has seen a three-week consecutive decline, losing 1.99% during this period. In contrast, the BSE Mid Cap index is showing resilience, gaining 0.13% today.

Piramal Pharma's year-to-date performance stands at a notable decline of 25.88%, contrasting sharply with the Sensex's gain of 3.47%. Over the past year, however, Piramal Pharma has managed a positive return of 15.75%, while the Sensex has slightly decreased by 0.62%.